首页 | 本学科首页   官方微博 | 高级检索  
检索        


Liver transplantation is an alternative treatment of hepatocellular carcinoma beyond the Milan criteria
Authors:Hsiu-Lung Fan  Teng-Wei Chen  Chung-Bao Hsieh  Hsiang-Chun Jan  Sheng-Chuan His  Chan De-Chuan  Jyh-Cherng Yu
Institution:a Division of General Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan
b Division of General Surgery, Department of Surgery, Cardinal Tien Hospital, Hsintien Taipei Hsien, 23137 Taiwan
c Division of General Surgery, Department of Surgery, Taoyuan Armed Forces General Hospital, Taoyuan, Taiwan, Republic of China
Abstract:

Background

The decision to perform liver transplantation (LT) or liver resection (LR) for patients with hepatocellular carcinoma (HCC) who are beyond the Milan criteria remains controversial.

Methods

We retrospectively analyzed outcome data for 179 patients with HCC beyond the Milan criteria who were treated with LR (n = 135) or LT (n = 44). Univariate and multivariate Cox proportional hazard models were established. Kaplan-Meier survival curves were generated, and a log-rank test was performed to compare group survival status.

Results

Patients who underwent LR group were significantly older, had a lower TNM stage, and were more likely to have unilateral disease and noncirrhotic liver. Significantly more patients in the LR group had recurrence (53.3% vs 29.5%) or died (61.5% vs 43.2%) than patients in the LT group. Recurrence-free survival rates were 11.9% for the LR group and 61.5% for the LT group. The median overall survival duration showed no statistically difference between the LR group (28.0 months) and the LT group (50.0 months).

Conclusions

LT may be the better choice for patients with HCC beyond the Milan criteria.
Keywords:Hepatocellular carcinoma  Liver resection  Liver transplantation  Milan criteria  Treatment  Outcome
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号